Summary
Twenty-one women with primary osteoporosis received an intramuscular injection of 100 IU of salmon calcitonin at 8am. Blood samples were collected up to 5 h postcalcitonin and urine was collected for 24 h in three periods of 8 h each. A significant fall of the total hydroxyproline excretion (THP) was observed in every period but the maximum effect took place 8–16 h postcalcitonin. The effect was more pronounced in those patients with a greater basal excretion of THP and in those with a more significant diminution of their bone mass. A significant diminution of the urinary excretion of calcium was found 8–24 h postcalcitonin, while phosphate excretion increased throughout the three 8 h periods. The effect of calcitonin in osteoporotic women was compared with the results obtained in 9 patients with Paget's disease. In absolute values the fall of THP excretion was significantly greater in the pagetic patients but the percentage diminution was not significantly different in osteoporotic women and in pagetic patients. Salmon calcitonin induced a significant acute diminution of bone turnover in patients with osteoporosis, as defined by decreases in total urinary hydroxyproline. The calcitonin-induced hypocalcemia does not seem to be an accurate index of the hormone action in osteoporosis.
Similar content being viewed by others
References
Gershberg H, Gireis M, Goldberg L, Duga J, St. Paul H (1973) The acute response to calcitonin in Paget's disease: its relationship to the serum alkaline phosphatase level and the effect of phosphate treatment. J Clin Endocrinol Metab 36:691–696
Chapuy MC, Meunier P, Terrier M, David L, Vignon G (1975) Effects biologiques à courte terme de la calcitonine synthétique de saumon dans la maladie de Paget. Pathol Biol 23:349–359
Blanc D, Chapuy MC, Meunier P (1977) Evaluation de l'activité osteoclastique par le test d'hypocalcemie provoquée par la calcitonine de saumon. Nouv Presse-méd 6:2489–2494
Galante L, Joplin G, Mac Intyre I, Woodhouse NJY (1973) The calcium-lowering effect of synthetic human, porcine and salmon calcitonins in patients with Paget's disease. Clin Science 44:605–610
Alexandre C, Chapuy MC, Meunier P (1979) Le test d'hypocalcemie provoquée par la calcitonine de saumon. Nouv Presse-méd 6:2489–2494
Chapuy MC, Meunier P, Alexandre C (1980) Comparison of the acute effects of human and salmon calcitonins in pagetic patients: relation with plasma calcitonin levels. Metab Bone Dis Rel Res 2:93–97
Chapuy MC, Muenier P (1981) Action antiosteoclastique de la calcitonine. Effet d'une faible dose. Nouv Presse-méd 10:2210–2211
Chapuy MC, Meunier P (1982) Comparison of the acute effect of eel and salmon calcitonin in pagetic patients. Horm Metabol Res 14:559–560
Bataille R, Sany J (1982) Clinical evaluation of myeloma osteoclastic bone lesions: induced hypocalcemia test using salmon calcitonin. Metab Bone Dis Rel Res 4:39–42
Ste-Marie LG, Charhon SA, Meunier PJ (1983) Le test d'hypocalcemie à la calcitonine a-t-il une utilité dans les ostéoporoses? Nouv Presse-méd 12:2883–2884.
Kivirikko KI, Laitinen O, Prockop J (1967) Modification of a specific assay for hydroxyproline in urine. Ann Biochem 19:249–257
Mautalen C, Tau C, Casco C, Fromm G (1984) Contenido mineral óseo en la población normal de Buenos Aires. Medicina (Buenos Aires) 44:356–360
Mazess RB, Cameron JR (1974) Bone mineral content in normal U. S. Whites. In: Mazess RB (ed) International Conference on Bine Mineral Measurement. Washington US Dept of Health, Education and Welfare. Publication no (NHI) 75, p 228
Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut III CR (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295–303
Wallach S, Conn SH, Atkins HL, Ellis KJ, Kohberger R, Alvia JF, Zanzi I (1977) Effect of salmon calcitonin on skeletal mass in osteoporosis. Current Therapeutic Research, vol 22:556–572
Krane SM, Harris ED, Singer FR, Potts JT (1973) Acute effects of calcitonin on bone formation in man. Metabolism 22:52–58
Meunier PJ, Sellami S, Briançon D, Edouard C (1981) Histological heterogeneity of apparently idiopathic osteoporosis. In: De Luca HF, Frost HM, Jee WSS, Johnston CC Jr, Parfitt AM (eds) Osteoporosis: recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 293–301
Carney S, Thompson L (1981) Acute effect of calcitonin on rat renal electrolyte transport. Am J Physiol, 240(F):F12-F16
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
González, D., Ghiringhelli, G. & Mautalen, C. Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women. Calcif Tissue Int 38, 71–75 (1986). https://doi.org/10.1007/BF02556832
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02556832